Settlement and Release Agreement - Theralink (Details Narrative) - USD ($) $ / shares in Units, $ in Millions |
12 Months Ended | |
---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
Business Acquisition [Line Items] | ||
Payments to Acquire Property, Plant, and Equipment | ||
Series E Preferred Stock [Member] | ||
Business Acquisition [Line Items] | ||
Stock Issued During Period, Shares, New Issues | 24,172 | |
Settlement and Release Agreement [Member] | ||
Business Acquisition [Line Items] | ||
Payments to Acquire Property, Plant, and Equipment | $ 1.1 | |
Proceeds from Sale of Notes Receivable | $ 1.1 | |
Settlement and Release Agreement [Member] | Series E Preferred Stock [Member] | ||
Business Acquisition [Line Items] | ||
Stock Issued During Period, Shares, New Issues | 24,172 | |
Preferred Stock, Convertible, Conversion Price | $ 3.641 |